Sustainable HPLC Method for Resmetirom, a Novel THR-β Agonist: Development, Validation and Greenness Assessment

已完结 10 由董建峰发布于 2025/11/7 11:31:47

DOI:10.1007/s10337-025-04429-0
作者：Khushi Dahiya, Sanjay Sharma
文献类型：期刊论文
补充材料：只需要正文

Springer

Abstract：Resmetirom (RMT), a new drug approved for the treatment of metabolic dysfunction-associated steatohepatitis and the present work describes the development and validation of a reversed-phase

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierFish skin collagen hydrolysate-based edible films blended with green tangerine peel extract: physicochemical properties, antioxidant activity, and gastrointestinal release